From the experimental laboratory to the patient: How does it happen?

Shock

Volumn 24, Issue 6, 2006, Pages 505-507

  Baue, Arthur E ^a  

^a Box 396 ^*  (United States)

Author keywords

Animals; ATP MgCl2, ethyl pyruvate; Clinical use; Discoveries; Drug studies; Potential therapeutic agents; Therapy; U.S. Patent Office

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ACETYLCYSTEINE; ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIOXIDANT; BICARBONATE; BRADYKININ ANTAGONIST; BUFFER; COMPLEMENT COMPONENT C1S INHIBITOR; DEXTRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ETACRYNIC ACID; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLAMINOMETHANE; LEPTIN; METHYLPREDNISOLONE; NITRIC OXIDE SYNTHASE INHIBITOR; PENTOXIFYLLINE; PHENOXYBENZAMINE; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RINGER SOLUTION; SELENIUM; STEROID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ACIDOSIS; CLINICAL RESEARCH; DRUG MECHANISM; DRUG TARGETING; FLUID THERAPY; FOOD AND DRUG ADMINISTRATION; HEMORRHAGIC SHOCK; HUMAN; INFLAMMATION; MICROCIRCULATION; NONHUMAN; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 33646771028     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000188327.82641.fe     Document Type: Review

References (11)

1. Chaudry IH, Baue AE: The use of substrates and energy in the treatment of shock. In: Lefer AM, Saba TM, Meela LM, eds: Advances in Shock Research, Vol 3. New York: Alan R. Liss, 1980, 27-46.
2. Baue AE, Chaudry IH: Some clinical adventures and misadventures. In: Lefer AM, Saba TM, Meela LM, eds: Advances in Shock Research, Vol 3. New York: Alan R. Liss, 1980, 67-75.
3. Fink MP: Ethyl pyruvate: a novel treatment for sepsis and shock. Minerva Anestesiol. 70:365-371, 2004.
4. Yang R, Uchiyama T, Watkins SK, Han X, Fink MP: Ethyl pyruvate reduces liver injury in a murine model of extrahepatic cholestasis. Shock 22:369-375, 2004.
5. Sappington PL, Fink ME, Yang R, Delude RL, Fink MP: Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock 20:521-528, 2003.
6. Venkataraman R, Kellum JA, Song M, Fink MP: Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 18:507-512, 2002.
7. Zingarelli B: Ethyl pyruvate: a simple solution? Crit Care Med 32:1603-1604, 2004.
8. Yang R, Uchiyama T, Albert SM, et al.: Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis. Crit Care Med 32:1453-1459, 2004.
9. Mulier KE, Beilman GJ, Conroy MJ, Taylor JH, Skarda DE, Hammer BE: Ringer's ethyl pyruvate in hemorrhagic shock and resuscitation does not improve early hemodynamics or tissue energetics. Shock 23:248-252, 2005.
10. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 9:517-524, 2003.
11. Kennedy D: The old file-drawer problem. Science 305:451, 2004.